You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》里昂下調三生製藥(01530.HK)目標價至5.75元 評級「跑贏大市」
阿思達克 08-26 15:32
里昂發表報告指,三生製藥(01530.HK)上半年收入按年微跌0.5%,遜於該行預期;純利則按年增長6.2%,符合預期,其中匯兌收益為2.51億元人民幣。另外,基於上半年業績,管理層將今年銷售指引由按年增長逾10%,降至單位數增長。 里昂下調三生製藥股份目標價,由7.4元降至5.75元,評級維持「跑贏大市」,並調低集團今年至2024年各年收入預測分別6.4%、10%及12.7%,盈利預測亦相應下調2.2%、7.6%及10.3%,反映其核心藥品的銷售呆滯及指引下調。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account